Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells.

Proliferation of human CD4+ alphabeta T cells expressing a natural killer cell activating receptor (NKAR) has been shown to be enhanced, particularly in response to low doses of antigen, if the target cells present appropriate human class I major histocompatibility complex (MHC) molecules. Here, we show that NKAR also enhance proliferation and killing of target cells by subsets of CD8+ alphabeta and CD8+ gammadelta T cells, as well as by NK cells. Strikingly, interferon gamma secretion from all of these types of lymphocytes was markedly increased by interaction of the NKAR with their MHC class I ligands, independently of enhancement of proliferation. Thus, the recognition of class I MHC molecules by NKAR on both T cells and NK cells may provide a regulatory mechanism that affects immune responses through the secretion of interferon gamma and possibly other cytokines. It represents a signal for cytokine secretion alternative and/or augmentative to that through the T cell receptor.

[1]  K. Smith,et al.  NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. , 1998, Journal of immunology.

[2]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[3]  J. Krieger,et al.  Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99. , 1997, Journal of immunology.

[4]  L. Moretta,et al.  p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. , 1997, International immunology.

[5]  O. Mandelboim,et al.  Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.

[6]  A. Fauci,et al.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  O. Mandelboim,et al.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules , 1996, The Journal of experimental medicine.

[8]  M. Colonna,et al.  Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C , 1996, The Journal of experimental medicine.

[9]  L. Lanier,et al.  Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C , 1996, The Journal of experimental medicine.

[10]  D. Marguet,et al.  Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. , 1996, Journal of immunology.

[11]  T. Saito,et al.  Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking , 1996, The Journal of experimental medicine.

[12]  Eric O Long,et al.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.

[13]  T. Mcclanahan,et al.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.

[14]  L. Moretta,et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.

[15]  H. Macdonald NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function , 1995, The Journal of experimental medicine.

[16]  L. Lanier,et al.  Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. , 1995, Journal of immunology.

[17]  L. Lanier,et al.  Development of human T and natural killer cells. , 1995, Blood.

[18]  Eric O Long,et al.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.

[19]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[20]  P. Parham,et al.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.

[21]  S. Ferrini,et al.  Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. , 1995, International immunology.

[22]  S. Sforzini,et al.  T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function , 1994, European journal of immunology.

[23]  L. Lanier,et al.  Identification of a common T/natural killer cell progenitor in human fetal thymus , 1994, The Journal of experimental medicine.

[24]  R. Pardi,et al.  CD45‐mediated regulation of LFA1 function in human natural killer cells. Anti‐CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules , 1993, European journal of immunology.

[25]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[26]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[27]  G. Trinchieri,et al.  Production of hematopoietic colony-stimulating factors by human natural killer cells , 1989, The Journal of experimental medicine.

[28]  G. Trinchieri,et al.  Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells , 1988, The Journal of experimental medicine.